137 related articles for article (PubMed ID: 7495191)
1. Long-term efficacy and cognitive effects of vigabatrin.
Ylinen A; Kälviäinen R; Riekkinen PJ
Acta Neurol Scand Suppl; 1995; 162():47-50. PubMed ID: 7495191
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin and carbamazepine monotherapy for newly diagnosed epilepsy.
Walker MC; Cockerell OC; Sander JW
Arch Neurol; 1996 Jun; 53(6):477-8. PubMed ID: 8660147
[No Abstract] [Full Text] [Related]
3. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
Murri L; Iudice A
Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
Kälviäinen R; Aikiä M; Saukkonen AM; Mervaala E; Riekkinen PJ
Arch Neurol; 1995 Oct; 52(10):989-96. PubMed ID: 7575227
[TBL] [Abstract][Full Text] [Related]
5. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children.
Zamponi N; Cardinali C
Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
Chadwick D
Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
[TBL] [Abstract][Full Text] [Related]
7. Rationalized polytherapy for epilepsy.
Goldsmith P; de Bittencourt PR
Acta Neurol Scand Suppl; 1995; 162():35-9. PubMed ID: 7495188
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies.
Gobbi G; Pini A; Bertani G; Menegati E; Tiberti A; Valseriati D; Besana D; Rasmini P; Guerrini R; Belmonte A; Veggiotti P; Resi C; Lanzi G; Capovilla G; Galeone D; Milani S
Epilepsy Res; 1999 May; 35(1):29-37. PubMed ID: 10232792
[TBL] [Abstract][Full Text] [Related]
9. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
Russ W
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.
Beran RG; Berkovic SF; Buchanan N; Danta G; Mackenzie R; Schapel G; Sheean G; Vajda F
Seizure; 1996 Dec; 5(4):259-65. PubMed ID: 8952010
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin monotherapy in resistant neonatal seizures.
Baxter PS; Gardner-Medwin D; Barwick DD; Ince P; Livingston J; Murdoch-Eaton D
Seizure; 1995 Mar; 4(1):57-9. PubMed ID: 7788110
[TBL] [Abstract][Full Text] [Related]
12. Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective.
Schmidt D
Acta Neurol Scand Suppl; 1995; 162():7-10. PubMed ID: 7495192
[TBL] [Abstract][Full Text] [Related]
13. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
Schapel GJ; Wallace SJ; Gordon GS
Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
[TBL] [Abstract][Full Text] [Related]
14. Effects of vigabatrin on partial seizures and cognitive function.
Grünewald RA; Thompson PJ; Corcoran R; Corden Z; Jackson GD; Duncan JS
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures.
Parker AP; Agathonikou A; Robinson RO; Panayiotopoulos CP
Dev Med Child Neurol; 1998 Aug; 40(8):517-9. PubMed ID: 9746003
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
Baulac M; Cavalcanti D; Semah F; Arzimanoglou A; Portal JJ
Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227
[TBL] [Abstract][Full Text] [Related]
17. Dose-response study of vigabatrin in children with refractory epilepsy.
Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between vigabatrin and impaired cognition.
Monaco F; Torta R; Cicolin A; Borio R; Varetto A; Bergamasco L; Vighetti S
J Int Med Res; 1997; 25(5):296-301. PubMed ID: 9364292
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study.
Tanganelli P; Regesta G
Epilepsy Res; 1996 Nov; 25(3):257-62. PubMed ID: 8956924
[TBL] [Abstract][Full Text] [Related]
20. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
Brodie MJ; Mumford JP
Epilepsy Res; 1999 Apr; 34(2-3):199-205. PubMed ID: 10210035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
